The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions
| Autor: | Takalo, Mari, Wittrahm, Rebekka, Wefers, Benedikt, Parhizkar, Samira, Jokivarsi, Kimmo, Kuulasmaa, Teemu, Mäkinen, Petra, Martiskainen, Henna, Wurst, Wolfgang, Xiang, Xianyuan, Marttinen, Mikael, Poutiainen, Pekka, Haapasalo, Annakaisa, Hiltunen, Mikko, Haass, Christian |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Phospholipase C gamma
Macrophage Macrophages Short Report Genetic Variation genetics [Alzheimer Disease] lcsh:Geriatrics immunology [Microglia] immunology [Phospholipase C gamma] lcsh:RC346-429 Knock-in mouse model PLCG2 immunology [Alzheimer Disease] Mice Inbred C57BL lcsh:RC952-954.6 Mice genetics [Phospholipase C gamma] Alzheimer Disease ddc:570 Animals Humans Microglia Gene Knock-In Techniques Alzheimer’s disease lcsh:Neurology. Diseases of the nervous system |
| Zdroj: | Molecular neurodegeneration 15(1), 52 (2020). doi:10.1186/s13024-020-00402-7 Molecular Neurodegeneration Molecular Neurodegeneration, Vol 15, Iss 1, Pp 1-14 (2020) |
| ISSN: | 7282-4905 |
| Popis: | Background Microglia-specific genetic variants are enriched in several neurodegenerative diseases, including Alzheimer’s disease (AD), implicating a central role for alterations of the innate immune system in the disease etiology. A rare coding variant in the PLCG2 gene (rs72824905, p.P522R) expressed in myeloid lineage cells was recently identified and shown to reduce the risk for AD. Methods To assess the role of the protective variant in the context of immune cell functions, we generated a Plcγ2-P522R knock-in (KI) mouse model using CRISPR/Cas9 gene editing. Results Functional analyses of macrophages derived from homozygous KI mice and wild type (WT) littermates revealed that the P522R variant potentiates the primary function of Plcγ2 as a Pip2-metabolizing enzyme. This was associated with improved survival and increased acute inflammatory response of the KI macrophages. Enhanced phagocytosis was observed in mouse BV2 microglia-like cells overexpressing human PLCγ2-P522R, but not in PLCγ2-WT expressing cells. Immunohistochemical analyses did not reveal changes in the number or morphology of microglia in the cortex of Plcγ2-P522R KI mice. However, the brain mRNA signature together with microglia-related PET imaging suggested enhanced microglial functions in Plcγ2-P522R KI mice. Conclusion The AD-associated protective Plcγ2-P522R variant promotes protective functions associated with TREM2 signaling. Our findings provide further support for the idea that pharmacological modulation of microglia via TREM2-PLCγ2 pathway-dependent stimulation may be a novel therapeutic option for the treatment of AD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|